Stock Events

Stock Events

BioRegenx 

$0.005500
0
-$0.00-31.25% Friday 17:53

Statistics

Day High
0.0055
Day Low
0.0051
52W High
0.025
52W Low
0.0055
Volume
55,000
Avg. Volume
8,098
Mkt Cap
5.34M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Financials

-985.21%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
4.68MRevenue
-46.11MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
ProShares S&P 500 Dynamic Buffer
FB
Mkt Cap0
Facebook, now Meta Platforms, offers social networking services, directly competing with Findit's content sharing and discovery features.
Alphabet
GOOGL
Mkt Cap4.24T
Google, through its social and content platforms like YouTube, competes in the content discovery and distribution space with Findit.
Snap
SNAP
Mkt Cap9.18B
Snapchat offers multimedia messaging, a direct competitor to Findit's content creation and sharing features.
Pinterest
PINS
Mkt Cap13.13B
Pinterest allows users to discover information using images, GIFs, and videos, competing with Findit's visual content discovery and sharing.
Microsoft
MSFT
Mkt Cap3.81T
Microsoft, through LinkedIn, competes in the professional networking and content sharing space, overlapping with some of Findit's offerings.
Trade Desk
TTD
Mkt Cap6.38B
The Trade Desk operates in digital advertising, competing with Findit in the online ad space and content promotion.
Spotify.
SPOT
Mkt Cap112.56B
Spotify, through its podcast and multimedia content, competes with Findit's audio and video content distribution.
Tencent Music Entertainment Group
TME
Mkt Cap14.03B
Tencent Music Entertainment offers music and audio entertainment services, competing with Findit's multimedia content sharing.
Alibaba Group
BABA
Mkt Cap295.54B
Alibaba, through its social and media businesses, competes in the digital content and e-commerce space, overlapping with Findit's market.

About

BioRegenx, Inc. develops, manufactures, and sells medical test equipment, science-based nutritional products, and AI-driven health monitoring technologies. Its products include the GlycoCheck system for microvascular health assessment, the Endocalyx Pro dietary supplement, and the DocSun AI engine for contactless vital sign monitoring. The company focuses on regenerative biotherapeutics, anti-aging, and non-invasive medical and wellness devices.
Show more...
CEO
William Resides
Employees
6
Country
United States
ISIN
US31772N1000

Listings

OTC Link
US
BRGX

0 Comments

Share your thoughts

FAQ

What is BioRegenx stock price today?▼
The current price of BRGX is $0.01 USD — it has decreased by -31.25% in the past 24 hours. Watch BioRegenx stock price performance more closely on the chart.
What is BioRegenx stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BioRegenx stocks are traded under the ticker BRGX.
Is BioRegenx stock price growing?▼
BRGX stock has fallen by -31.25% compared to the previous week, the month change is a -26.67% fall, over the last year BioRegenx has showed a -46.08% decrease.
What is BioRegenx market cap?▼
Today BioRegenx has the market capitalization of 5.34M
What is BioRegenx revenue for the last year?▼
BioRegenx revenue for the last year amounts to 4.68M USD.
What is BioRegenx net income for the last year?▼
BRGX net income for the last year is -46.11M USD.
How many employees does BioRegenx have?▼
As of September 06, 2026, the company has 6 employees.
In which sector is BioRegenx located?▼
BioRegenx operates in the Health & Wellness sector.
When did BioRegenx complete a stock split?▼
BioRegenx has not had any recent stock splits.
Where is BioRegenx headquartered?▼
BioRegenx is headquartered in Chattanooga, United States.